Literature DB >> 7744859

Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.

M E Coleman1, F DeMayo, K C Yin, H M Lee, R Geske, C Montgomery, R J Schwartz.   

Abstract

The avian skeletal alpha-actin gene was used as a template for construction of a myogenic expression vector that was utilized to direct expression of a human IGF-I cDNA in cultured muscle cells and in striated muscle of transgenic mice. The proximal promoter region, together with the first intron and 1.8 kilobases of 3'-noncoding flanking sequence of the avian skeletal alpha-actin gene directed high level expression of human insulin-like growth factor I (IGF-I) in stably transfected C2C12 myoblasts and transgenic mice. Expression of the actin/IGF-I hybrid gene in C2C12 muscle cells increased levels of myogenic basic helix-loop-helix factor and contractile protein mRNAs and enhanced myotube formation. Expression of the actin/IGF-I hybrid gene in mice elevated IGF-I concentrations in skeletal muscle 47-fold resulting in myofiber hypertrophy. IGF-I concentrations in serum and body weight were not increased by transgene expression, suggesting that the effects of transgene expression were localized. These results indicate that sustained overexpression of IGF-I in skeletal muscle elicits myofiber hypertrophy and provides the basis for manipulation of muscle physiology utilizing skeletal alpha-actin-based vectors.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1995        PMID: 7744859     DOI: 10.1074/jbc.270.20.12109

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  173 in total

1.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 3.  Strength training in the elderly: effects on risk factors for age-related diseases.

Authors:  B F Hurley; S M Roth
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

4.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle.

Authors:  Ana M Fernández; Joëlle Dupont; Roger P Farrar; Sukho Lee; Bethel Stannard; Derek Le Roith
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 5.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

Review 6.  IGF-I isoforms and ageing skeletal muscle: an 'unresponsive' hypertrophy agent?

Authors:  Espen E Spangenburg
Journal:  J Physiol       Date:  2003-02-15       Impact factor: 5.182

7.  IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase.

Authors:  Vania De Arcangelis; Dario Coletti; Marco Conti; Michel Lagarde; Mario Molinaro; Sergio Adamo; Georges Nemoz; Fabio Naro
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

8.  Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor.

Authors:  O Delbono; M Renganathan; M L Messi
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

9.  Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.

Authors:  Ka-Man V Lai; Michael Gonzalez; William T Poueymirou; William O Kline; Erqian Na; Elizabeth Zlotchenko; Trevor N Stitt; Aris N Economides; George D Yancopoulos; David J Glass
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.

Authors:  Elizabeth M Wilson; Jolana Tureckova; Peter Rotwein
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.